BioTelemetry, Inc. Named to Fortune Magazine’s 100 Fastest-Growing Companies List
September 03 2019 - 4:05PM
BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical
technology company focused on the delivery of health information to
improve quality of life and reduce cost of care, announced today it
has been ranked 31st on Fortune Magazine’s 100 Fastest-Growing
Companies list for 2019. The ranking is based on the combination of
revenue growth, earnings growth and the three-year annualized total
return. It applies to U.S. publicly traded companies.
“Being recognized on Fortune’s 100 Fastest-Growing Companies
list is a testament to the incredible work we are doing to deliver
our life-saving technology and help improve quality of care,” said
Joseph H. Capper, President and Chief Executive Officer of
BioTelemetry. “We are passionate about connecting people to
solutions that save lives and are constantly evaluating
opportunities that allow us to extend our reach and product
offerings. Our continued growth reflects our focus, commitment and
passion for the important work we do each day.”
BioTelemetry is advancing health by providing best-in-class
technology and services that enable healthcare providers to
remotely monitor and diagnose patients and clinical research
subjects in a more efficient, accurate and cost-effective manner.
Today, BioTelemetry processes over four billion heartbeats per day,
monitors over one million patients each year, supports some of the
largest clinical trials and is pioneering patient-care monitoring
by connecting people with their care teams. It is one of the
largest, fastest growing and most profitable connected health
companies.
To access the full list of companies, please visit:
https://fortune.com/100-fastest-growing-companies/2019/.
About BioTelemetry
BioTelemetry, Inc. is the leading remote medical technology
company focused on delivery of health information to improve
quality of life and reduce cost of care. We provide remote cardiac
monitoring, remote blood glucose monitoring, centralized core lab
services for clinical trials and original equipment manufacturing
that serves both healthcare and clinical research customers. More
information can be found at www.gobio.com.
|
|
|
Contact: |
|
BioTelemetry, Inc. |
|
|
Heather C. Getz |
|
|
Investor Relations |
|
|
Executive Vice President,
Chief Financial Officer |
|
|
800-908-7103 |
|
|
investorrelations@biotelinc.com |
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024